Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Central da Visão partners with over 50 clinics in 14 Brazilian states to provide affordable access to eye surgeries—primarily cataract and refractive procedures—by utilizing unused clinic hours. The company generated $1M in revenue in 2023 and recently raised a $1.7M Series A round to expand its technology platform and geographic reach. It addresses the large unmet need for vision correction among patients facing long public healthcare wait times.
Clinical results are not published as drug trials but patient testimonials indicate high satisfaction rates with surgical outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central da Visão.